0.6137
전일 마감가:
$0.6215
열려 있는:
$0.635
하루 거래량:
2.33M
Relative Volume:
1.69
시가총액:
$73.82M
수익:
-
순이익/손실:
$-93.61M
주가수익비율:
-0.2909
EPS:
-2.11
순현금흐름:
$-71.16M
1주 성능:
-8.33%
1개월 성능:
-21.17%
6개월 성능:
-23.75%
1년 성능:
-45.69%
Immunic Inc Stock (IMUX) Company Profile
명칭
Immunic Inc
전화
(332) 255-9818
주소
1200 AVENUE OF THE AMERICAS, NEW YORK
IMUX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
IMUX
Immunic Inc
|
0.6137 | 74.76M | 0 | -93.61M | -71.16M | -2.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.71 | 114.69B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
752.62 | 77.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
850.95 | 54.05B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
391.50 | 52.52B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
196.92 | 42.02B | 447.02M | -1.18B | -906.14M | -6.1812 |
Immunic Inc Stock (IMUX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-07 | 개시 | Roth Capital | Buy |
| 2025-09-29 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-25 | 개시 | William Blair | Outperform |
| 2024-11-25 | 개시 | H.C. Wainwright | Buy |
| 2024-09-09 | 재개 | Leerink Partners | Outperform |
| 2024-08-27 | 개시 | B. Riley Securities | Buy |
| 2022-10-21 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-19 | 재개 | H.C. Wainwright | Buy |
| 2021-04-15 | 개시 | Aegis Capital | Buy |
| 2021-03-24 | 개시 | JMP Securities | Mkt Outperform |
| 2020-10-02 | 개시 | SVB Leerink | Outperform |
| 2020-08-26 | 개시 | Piper Sandler | Overweight |
| 2020-08-07 | 재개 | ROTH Capital | Buy |
| 2020-07-20 | 개시 | BMO Capital Markets | Outperform |
| 2020-06-05 | 개시 | Wedbush | Outperform |
| 2020-05-11 | 개시 | H.C. Wainwright | Buy |
| 2020-03-25 | 개시 | ROTH Capital | Buy |
| 2019-07-11 | 개시 | Chardan Capital Markets | Buy |
모두보기
Immunic Inc 주식(IMUX)의 최신 뉴스
683 Capital Management LLC Reduces Stake in Immunic, Inc. $IMUX - Defense World
Immunic, Inc. (NASDAQ:IMUX) Given Average Rating of “Buy” by Analysts - Defense World
Immunic, Inc. (NASDAQ:IMUX) Given Average Rating of "Buy" by Analysts - MarketBeat
JANUS HENDERSON GROUP PLC Acquires Significant Stake in Immunic Inc - GuruFocus
How does Immunic Inc (IMUX) change from a tortoise to a hare? - setenews.com
Immunic’s long-term treatment hope for multiple sclerosis – ICYMI - Proactive financial news
Operating income of Immunic, Inc. – HAM:10VA - TradingView
Will Immunic Inc. stock deliver better than expected guidanceRisk Management & Real-Time Buy Signal Alerts - Newser
How risky is Immunic Inc. stock nowJuly 2025 Reactions & Short-Term High Return Strategies - Newser
Will Immunic Inc. (10VA) stock return to pre crash levels2025 Fundamental Recap & Consistent Profit Alerts - Newser
How supply chain issues affect Immunic Inc. stockMarket Activity Recap & Weekly Sector Rotation Insights - Newser
Why Immunic Inc. (10VA) stock is a strong analyst pickPortfolio Gains Summary & Technical Pattern Alert System - Newser
Can Immunic Inc. (10VA) stock withstand sector downturnsTrade Exit Summary & Real-Time Buy Zone Alerts - Newser
Is Immunic Inc. stock near bottom after declineOil Prices & Daily Momentum Trading Reports - Newser
How Immunic Inc. stock performs in stagflation2025 Investor Takeaways & Target Return Focused Picks - Newser
Immunic marks International Day of Persons with Disabilities with hope for MS sufferers - Proactive financial news
What consensus target says about Immunic Inc. (10VA) stockWeekly Risk Summary & Safe Capital Growth Stock Tips - Newser
Why Immunic Inc. stock is considered a top pickPortfolio Value Summary & AI Based Buy/Sell Signal Reports - Newser
Will Immunic Inc. (10VA) stock outperform Dow JonesTrade Analysis Summary & Technical Confirmation Trade Alerts - Newser
Will Immunic Inc. (10VA) stock outperform global peers2025 Market Trends & Weekly Watchlist for Hot Stocks - Newser
Immunic (IMUX) Stock Analysis Report | Financials & Insights - Benzinga
B. Riley Has Bullish Estimate for Immunic FY2025 Earnings - MarketBeat
Immunic to Participate in the 8th Annual Evercore ISI Healthcare Conference in December - Sahm
What is B. Riley’s Forecast for Immunic FY2025 Earnings? - Defense World
Will Immunic Inc. (10VA) stock benefit from mergersWeekly Investment Report & Stepwise Entry/Exit Trade Alerts - moha.gov.vn
What is B. Riley’s Estimate for Immunic Q1 Earnings? - Defense World
B. Riley Forecasts Immunic's Q1 Earnings (NASDAQ:IMUX) - MarketBeat
Immunic (NASDAQ: IMUX) to present at 8th Evercore ISI Healthcare Conference on Dec. 4 - Stock Titan
Immunic announces attendance at upcoming Evercore ISI Healthcare Conference - Proactive financial news
Immunic Inc (IMUX) Clearly Signals Buy-Into the Stock: Don’t ignore the signals - Setenews
Analysts Offer Predictions for Immunic FY2025 Earnings - MarketBeat
Immunic FY2025 EPS Boosted by Brookline Capital Management - MarketBeat
Immunic (NASDAQ:IMUX) Upgraded at Chardan Capital - Defense World
Immunic Inc. (IMUX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Equities Analysts Issue Forecasts for Immunic Q1 Earnings - MarketBeat
How Immunic Inc. stock performs in weak economyJuly 2025 WrapUp & Entry Point Strategy Guides - newser.com
Is Immunic Inc. stock a buy before product launchesQuarterly Profit Summary & Detailed Earnings Play Strategies - newser.com
Why Immunic Inc. stock is trending among retail traders2025 Institutional Moves & Weekly Watchlist for Consistent Profits - newser.com
Forecasting Immunic Inc. price range with options dataWeekly Investment Report & Fast Momentum Entry Tips - newser.com
Chardan Capital Initiates Coverage of Immunic (IMUX) with Buy Recommendation - MSN
Using portfolio simulators with Immunic Inc. includedJuly 2025 Price Swings & High Accuracy Trade Signal Alerts - newser.com
Immunic Inc (IMUX) Performance and Fundamentals Dashboard tells a completely different story - Setenews
Immunic Inc (IMUX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
Immunic Inc 주식 (IMUX) 내부자 거래
| 내부자 거래 | 관계 | 날짜 | 거래 | 비용 | #주식 | 가치 ($) | #주식 총계 |
|---|---|---|---|---|---|---|---|
| Tardio Jason | President and COO |
Jun 05 '25 |
Buy |
0.79 |
12,512 |
9,884 |
12,512 |
| Vitt Daniel | CEO and Director |
Jun 04 '25 |
Buy |
0.77 |
15,000 |
11,550 |
29,000 |
| Neermann Joerg | Director |
Jun 04 '25 |
Buy |
0.77 |
70,000 |
53,900 |
170,000 |
| Neermann Joerg | Director |
Jun 05 '25 |
Buy |
0.76 |
30,000 |
22,800 |
200,000 |
| Whaley Glenn | Chief Financial Officer |
Jun 03 '25 |
Buy |
0.71 |
45,000 |
32,076 |
95,510 |
| Rudick Richard Alan | Director |
Jun 03 '25 |
Buy |
0.70 |
143,075 |
100,024 |
230,375 |
자본화:
|
볼륨(24시간):